4098979
UC RESULTS: EXPLORING CLINICAL OUTCOMES AND LONG-TERM SAFETY OF A JAK INHIBITOR FOR PATIENTS WITH UC
Date
May 20, 2024
Presenter
Cleveland Clinic
Tracks
Related Products
EXHALED BREATH ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IS ASSOCIATED WITH LUMINAL DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
The evaluation of volatile organic compounds (VOCs) in exhaled breath shows promise as an entirely non-invasive strategy to evaluate for inflammation with high patient acceptance…
DEVELOPMENT AND VALIDATION OF A RISK CALCULATOR FOR MORTALITY AMONG GENERAL SURGERY PATIENTS AT THE TIME OF INTER-HOSPITAL TRANSFER
An incisional hernia (IH) is one of the most frequent complications after a laparotomy, affecting between 10 -20% of patients…
COST-EFFECTIVENESS OF A BIOMARKER MONITORING STRATEGY COMPARED TO ENDOSCOPIC MONITORING IN LOW-RISK POSTOPERATIVE CROHN’S DISEASE.
INTRODUCTION: Recent guidelines propose a fecal calprotectin (FCP) monitoring strategy in the year after Crohn’s disease (CD) resection for low-risk individuals or those receiving pharmacologic prophylaxis to prevent postoperative recurrence (POR)…
